{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/seborrhoeic-dermatitis/management/seborrhoeic-dermatitis-scalp-beard/","result":{"pageContext":{"chapter":{"id":"4172af9c-8f8b-5bcc-a160-ca83f520099c","slug":"seborrhoeic-dermatitis-scalp-beard","fullItemName":"Scenario: Seborrhoeic dermatitis - scalp and beard","depth":2,"htmlHeader":"<!-- begin field ca160350-2bcf-46c2-badb-9c0448644a8b --><h2>Scenario: Seborrhoeic dermatitis - scalp and beard</h2><!-- end field ca160350-2bcf-46c2-badb-9c0448644a8b -->","summary":"Covers what advice to give, how to manage seborrhoeic dermatitis of the scalp and beard areas, and when to follow up or refer.","htmlStringContent":"<!-- begin item dee011ef-0b50-45e0-a567-0852697c55b9 --><!-- begin field e0ad081c-4d69-4895-bfd9-acbc0158da1b --><p>From age 12 months onwards.</p><!-- end field e0ad081c-4d69-4895-bfd9-acbc0158da1b --><!-- end item dee011ef-0b50-45e0-a567-0852697c55b9 -->","topic":{"id":"b328d01a-a44a-57e1-8920-22321b4c6c8b","topicId":"67c69cb5-e030-443e-802f-758ce0fe90f8","topicName":"Seborrhoeic dermatitis","slug":"seborrhoeic-dermatitis","lastRevised":"Last revised in February 2019","chapters":[{"id":"2c32aabf-f751-57c2-9fb1-bfd7e4c7e58d","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"96bfb0b4-09f0-5525-aaf3-ca2354a87cb4","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"9bf8c16e-f128-5c6a-b6e8-d4223dcf2346","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"debcdac6-7ef3-5820-90b8-353614354fc7","slug":"changes","fullItemName":"Changes"},{"id":"32308918-ad23-5b7d-a1c5-7c7a4edf3e35","slug":"update","fullItemName":"Update"}]},{"id":"efc69a37-1a91-539d-b4ce-b1cfc1d48baf","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"09ce3910-2aa3-537d-97db-f473bf3f3c99","slug":"goals","fullItemName":"Goals"},{"id":"37776aed-67d4-5001-8e82-0fec56ecaa71","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"2638b372-65f4-549c-9c2d-fff4cf1c933d","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"df03f868-28e0-52a9-9f30-aecfccaa745c","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"bf290438-2d1b-5233-a43a-e3fe0cbccaab","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"d66aeca6-f9ff-5104-94d3-d115d20ad7d1","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"5f9559ed-2d1c-52f3-ae50-cb983d1b7c7c","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"025302eb-268d-585c-b9a4-d83b4dbb0e5b","slug":"definition","fullItemName":"Definition"},{"id":"43d0a434-92b2-5c53-b4bd-f8ab32a8c0a3","slug":"causes","fullItemName":"Causes"},{"id":"0f04315e-ba03-5be7-a5dc-c724c1e3fe90","slug":"prevalence","fullItemName":"Prevalence"},{"id":"ad49e37a-e725-5ad1-9e7b-f84a79627169","slug":"complications","fullItemName":"Complications"},{"id":"50cfb7dd-1ad7-5d22-9c7e-8472fb0af48c","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"26dec6e1-8806-50b7-869d-1e010fa15e89","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"1f674962-dade-5ce5-9b92-60820da005f7","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"f384b060-7f9e-593e-8a77-6bbf957fd0c4","slug":"assessment","fullItemName":"Assessment"},{"id":"2b98bc5c-ae88-522e-89c4-79e05d301c3f","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"521d1a4a-9184-5872-ab66-2a3fed074cc8","fullItemName":"Management","slug":"management","subChapters":[{"id":"ca5edad5-d74c-565f-b254-2c59bed62420","slug":"seborrhoeic-dermatitis-infants","fullItemName":"Scenario: Seborrhoeic dermatitis - infants"},{"id":"4172af9c-8f8b-5bcc-a160-ca83f520099c","slug":"seborrhoeic-dermatitis-scalp-beard","fullItemName":"Scenario: Seborrhoeic dermatitis - scalp and beard"},{"id":"ad81b0ed-2e0c-5a1d-a7a0-e823d40d7ca4","slug":"seborrhoeic-dermatitis-face-body","fullItemName":"Scenario: Seborrhoeic dermatitis - face and body"},{"id":"715da1f8-f458-5eec-96e8-85e22060d505","slug":"seborrhoeic-dermatitis-severe-or-widespread","fullItemName":"Scenario: Seborrhoeic dermatitis - severe or widespread"}]},{"id":"bac53cb4-0b97-5d4b-8ce4-07a9584a5e4f","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"970b1e50-a3fc-503d-bbe8-29ecfa575d20","slug":"products-available-otc","fullItemName":"Products available OTC"},{"id":"9b1c8434-e7ce-5cd0-8c49-9e1076fbcecb","slug":"topical-imidazoles","fullItemName":"Topical imidazoles"},{"id":"d35c5c70-d96b-5a9a-a708-2e051cf3cece","slug":"topical-corticosteroids","fullItemName":"Topical corticosteroids"}]},{"id":"b5cb8438-116a-5790-9b0f-2a480c577056","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"03823e51-3fec-53db-8dde-3fbe6e94526c","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"364fda13-808d-599d-84cd-2b31ed7d0d94","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"fd9a5e23-6ee9-503f-bbc4-7239d8555e0e","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"1120e62a-fd06-536e-8caf-945332e36549","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"214850c4-e7af-5924-9a63-09325facd062","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"bfa9b404-d181-55eb-a3b2-8da0ee4edb43","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"5171db55-6873-590e-b670-2d66a4b1b1eb","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"521d1a4a-9184-5872-ab66-2a3fed074cc8","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"11da6b87-fa15-5e12-925d-79f662ffbb5e","slug":"management-of-scalp-beard","fullItemName":"Management of scalp and beard","depth":3,"htmlHeader":"<!-- begin field 372fe4d0-71e5-4429-b8a0-160dc24ff7f7 --><h3>How should I manage seborrhoeic dermatitis of the scalp and beard?</h3><!-- end field 372fe4d0-71e5-4429-b8a0-160dc24ff7f7 -->","summary":null,"htmlStringContent":"<!-- begin item 73803946-09dd-4332-891b-82d27b9c4f15 --><!-- begin field c2893d33-ba7e-4186-ba54-c31042871f3e --><ul><li>Advise the person:<ul><li>That seborrhoeic dermatitis in adults is a chronic condition and long‐term maintenance treatment may be needed — some people may only require intermittent treatment for flares.</li><li>To avoid use of soap and shaving cream on the face if they cause irritation — non-greasy emollient soap substitutes should be used.</li><li>That stress may exacerbate seborrhoeic dermatitis and lead to flares.</li></ul></li><li>Provide patient information — available from :<ul><li>The British Association of Dermatologists — <a data-hyperlink-id=\"1fdb4235-dad0-4a5f-9a80-a9ff00bd27ff\" href=\"http://www.bad.org.uk/for-the-public/patient-information-leaflets/seborrhoeic-dermatitis\" target=\"_blank\">Seborrhoeic dermatitis</a>.</li><li>The National Eczema Association — <a data-hyperlink-id=\"94db231b-e9fa-440b-86f9-a9ff00bd2865\" href=\"https://nationaleczema.org/eczema/types-of-eczema/seborrheic-dermatitis/\" target=\"_blank\">Seborrhoeic dermatitis</a>.</li></ul></li><li>Treat seborrhoeic dermatitis of the scalp and beard in adolescents and adults with:<ul><li>Ketoconazole 2% shampoo (twice a week for 4 weeks, then once every 1-2 weeks for maintenance) or selenium sulphide shampoo (twice a week for 2 weeks [contraindicated in pregnancy]).<ul><li>Scales can be removed before shampooing by applying warm mineral or olive oil (for mild crusting) or a keratolytic preparation (for example salicylic acid and coconut oil for thicker scale) for several hours before shampooing.</li><li>Shampoo should be left on for 5 minutes before rinsing off.</li></ul></li><li>Other medicated shampoos such as zinc pyrithione, coal tar, or salicylic acid can be used, if ketoconazole or selenium sulphide are not appropriate or acceptable to the person — many preparations can be purchased over the counter.<ul><li>For more information see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/prescribing-information/products-available-otc/\">Products available over-the-counter</a>.</li></ul></li></ul></li><li> If the person has severe itching of the scalp:<ul><li>Consider co-prescribing a short course (maximum 4 weeks of treatment) of a topical corticosteroid scalp application such as betamethasone valerate 0.1% or mometasone furoate 0.1% once a day.</li><li>Potent topical corticosteroid scalp applications are <em>not</em> suitable for application to the beard, because of adverse effects such as thinning of the skin on the face.</li><li>Topical corticosteroids are not appropriate for continuous long-term use — use as maintenance treatment is not recommended.</li><li>For more information on prescribing corticosteroids see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/corticosteroids-topical-skin-nose-eyes/\">Corticosteroids - topical (skin), nose, and eyes</a>.</li></ul></li><li>Routine follow up is not usually required, however, the person should be advised to attend for review if:<ul><li>Response to treatment is poor.</li><li>Symptoms worsen despite treatment.</li><li>Signs of infection (for example crusting, oozing, bleeding) develop.</li></ul></li><li>Consider referral to a dermatologist if there is:<ul><li>Diagnostic uncertainty.</li><li>Failure to respond to routine treatment — consider drug resistance and <a class=\"topic-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/diagnosis/differential-diagnosis/\">other causes</a>.</li><li>Severe or widespread seborrhoeic dermatitis — for more information, see <a class=\"topic-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/management/seborrhoeic-dermatitis-severe-or-widespread/\">Scenario: Seborrhoeic dermatitis - severe or widespread</a>.</li></ul></li></ul><!-- end field c2893d33-ba7e-4186-ba54-c31042871f3e --><!-- end item 73803946-09dd-4332-891b-82d27b9c4f15 -->","subChapters":[{"id":"9aef79a3-c6c5-5fc0-a443-c41dc1ebae60","slug":"basis-for-recommendation-ddf","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 75fda67a-b570-4ecf-be73-a83e1cf5cf7f --><h4>Basis for recommendation</h4><!-- end field 75fda67a-b570-4ecf-be73-a83e1cf5cf7f -->","summary":null,"htmlStringContent":"<!-- begin item ddf93951-1707-47ea-b41d-9bfbf29a129f --><!-- begin field 228be03c-dabe-49fe-977e-fa23d3353a11 --><p>The recommendations on the management of seborrhoeic dermatitis affecting the scalp and beard are based on clinical guidance from the World Health Organisation <em>Evidence and recommendations on seborrhoeic dermatitis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">WHO, 2014</a>], <em>Evidence-based Danish guidelines for the treatment of Malassezia-related skin diseases</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Hald, 2015</a>] and the Primary Care Dermatological Society <em>Seborrhoeic eczema</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">PCDS, 2016</a>], and expert opinion from the British Association of Dermatology [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">BAD, 2018</a>], Rook’s textbook of dermatology [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Wakelin, 2016</a>] and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Dessinioti, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Gary, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Ooi, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Borda, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Clark, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">BMJ Best Practice, 2018</a>].</p><h5>General advice </h5><ul><li>As treatment is suppressive rather than curative seborrhoeic dermatitis often recurs after treatment has stopped — maintenance treatment may be required for months or even years [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Gary, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Wakelin, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">BAD, 2018</a>].</li><li>Cosmetic products containing alcohol solutions usually aggravate inflamed skin and should be avoided [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Berth-Jones, 2010</a>]. Soap and shaving cream may be irritating when applied to affected skin. Emollients or emollient soap substitutes can be used instead [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Plewig and Jansen, 2008</a>].</li><li>Expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Gary, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Borda, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Clark, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Okokon, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">BMJ Best Practice, 2018</a>] is that stress may exacerbate seborrhoeic dermatitis.</li></ul><h5>Topical treatment</h5><ul><li>Treatment with ketoconazole 2% shampoo or selenium sulphide shampoo is widely recommended in clinical guidance [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">PCDS, 2016</a>], patient information from the British Association of Dermatology [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">BAD, 2018</a>], Rook’s textbook of dermatology [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Wakelin, 2016</a>] and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Dessinioti, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Gary, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Ooi, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Borda, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Clark, 2015</a>].</li><li>The recommendation on removal of adherent crusts or scales prior to the use of shampoo is based on clinical guidance [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">PCDS, 2016</a>] and advice from the British Association of Dermatologists [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">BAD, 2018</a>].</li><li>A Cochrane review (51 studies, n=9052) of the effectiveness of antifungals in treatment of seborrhoeic dermatitis concluded that ketoconazole is more effective than placebo [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Okokon, 2015</a>]:<ul><li>Topical ketoconazole 2% treatment showed a 31% lower risk of failed clearance compared to placebo at four weeks of follow‐up (RR 0.69, 95% CI 0.59–0.81, eight studies, low‐quality evidence).</li><li>Treatment with ketoconazole had a remission rate similar to steroids (RR 1.17, 95% CI 0.95 to 1.44, six studies, low‐quality evidence) and a lower rate of side effects (44% lower in the ketoconazole group than in the steroid group [RR 0.56, 95% CI 0.32 to 0.96, eight studies, moderate‐quality evidence]).</li></ul></li><li>There is little published evidence that medicated shampoos such as zinc pyrithione, coal tar, or salicylic acid are effective, however, they are recommended in several literature sources, and are widely used in treatment of seborrhoeic dermatitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Gary, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Ooi, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Clark, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Wakelin, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">BAD, 2018</a>].</li><li>Consensus expert opinion supports the limited use of topical corticosteroids in combination with antifungals for treatment of seborrhoeic dermatitis of the scalp [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Naldi, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Dessinioti, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Borda, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Wakelin, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">BAD, 2018</a>].<ul><li>A Cochrane review [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Kastarinen, 2014</a>] looking at topical anti-inﬂammatory agents for seborrhoeic dermatitis of the face or scalp (36 randomized controlled trials (n=2706 participants); 31 studies examined topical steroids) concluded that topical steroids are an effective treatment for seborrhoeic dermatitis of the face and scalp in adolescents and adults, with no differences between mild and strong steroids in the short-term.</li><li>Steroid treatment resulted in total clearance more often than placebo in short-term trials (four weeks or less) (relative risk (RR) 3.76, 95% conﬁdence interval (CI) 1.22 to 11.56, three RCTs, 313 participants) and in one long-term trial (lasting 12 weeks). Steroids were also more effective in reducing erythema, scaling, and pruritus. Adverse effects were similar in both groups.</li></ul></li></ul><h5>Prevention of recurrence</h5><ul><li>The recommendation to use an antifungal shampoo once a week or once every two weeks to prevent recurrence is based on expert opinion [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Dessinioti, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Gary, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Ooi, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Borda, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Clark, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">PCDS, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Wakelin, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">BAD, 2018</a>].</li><li>Continuous long-term use of topical steroids increases the risk of local and systemic adverse reactions [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">ABPI, 2015a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">BNF 76, 2018</a>], their use is not recommended for prevention of recurrence.</li></ul><h5>Follow up</h5><ul><li>CKS could find no guidelines or evidence on the follow up of seborrhoeic dermatitis of the scalp and beard — recommendations are pragmatic.</li></ul><h5>Referral</h5><ul><li>The recommendation to refer if there is diagnostic uncertainty or the person is not responding to topical treatment is supported by clinical guidance [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">PCDS, 2016</a>] and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Ooi, 2014</a>].</li><li>Immunodeficiency (including HIV infection) should be considered where seborrhoeic dermatitis is widespread or severe [<a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">WHO, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/seborrhoeic-dermatitis/references/\">Wakelin, 2016</a>].</li></ul><!-- end field 228be03c-dabe-49fe-977e-fa23d3353a11 --><!-- end item ddf93951-1707-47ea-b41d-9bfbf29a129f -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}